Gene: SLC6A8
Official Full Name: solute carrier family 6 member 8provided by HGNC
Gene Summary: The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35386 | SLC6A8 Knockout cell line (HeLa) | Human | SLC6A8 | 1:3~1:6 | Negative | Online Inquiry |
KO35387 | SLC6A8 Knockout cell line (HCT 116) | Human | SLC6A8 | 1:2~1:4 | Negative | Online Inquiry |
KO35388 | SLC6A8 Knockout cell line (HEK293) | Human | SLC6A8 | 1:3~1:6 | Negative | Online Inquiry |
KO35389 | SLC6A8 Knockout cell line (A549) | Human | SLC6A8 | 1:3~1:4 | Negative | Online Inquiry |
SLC6A8 Gene Knockout Cell Lines are genetically engineered cell lines wherein the SLC6A8 gene, known for coding the creatine transporter, has been selectively disrupted. This product serves as a vital tool for researchers investigating the physiological role of creatine in cellular metabolism and its implications in various diseases, particularly those related to neurodegenerative disorders and muscular pathologies. The SLC6A8 knockout impairs the uptake of creatine, allowing scientists to study the consequences of its depletion on cellular function and identity.
The primary mechanism of action involves the absence of the SLC6A8 transporter, leading to altered intracellular levels of creatine. Researchers can utilize these cell lines to elucidate the subsequent biochemical pathways affected by this deficiency, providing insights into energy metabolism, signaling cascades, and substrate availability for anabolic processes. These cell lines are particularly important in studies focusing on creatine's role in high-energy demanding tissues such as muscle and brain, enabling targeted exploration into conditions like creatine transport deficiency syndrome.
In the realm of research and clinical applications, the SLC6A8 knockout cell lines represent a step forward in modeling pathological states associated with energy metabolism disruptions. The unique advantage of these cell lines over conventional models lies in their precision and specificity. Unlike traditional methods, these genetically modified cells offer a more accurate representation of the dysfunctions associated with SLC6A8, facilitating more relevant results and enhancing the reliability of experimental outcomes.
For researchers and clinicians, utilizing SLC6A8 Gene Knockout Cell Lines aids in the development of potential therapeutic strategies targeting metabolic diseases, thereby driving innovation in treatment paradigms. The availability of these specialized cell lines is supported by our company's extensive expertise in genetic engineering and biomanufacturing, ensuring high-quality, reproducible products tailored for cutting-edge scientific exploration.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.